Suppr超能文献

使用稳定同位素标记的维拉帕米同时测定 D,L-维拉帕米的静脉和口服药代动力学参数。

Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.

作者信息

Eichelbaum M, Somogyi A, von Unruh G E, Dengler H J

出版信息

Eur J Clin Pharmacol. 1981 Jan;19(2):133-7. doi: 10.1007/BF00568400.

Abstract

Following i.v. administration, the plasma concentration-time curve of verapamil could best be described by either a mono- or biexponential equation. Total plasma clearance (1.26 1/min) approached liver blood flow (1.51/min), so it can be concluded that its clearance is liver blood flow-dependent. Although absorption was almost complete after oral administration, absolute bioavailability (20%) was low, due to extensive hepatic first-pass metabolism. The approach using stable isotope-labelled and unlabelled drug permits simultaneous administration by the intravascular and extravascular routes, thus allowing determination of absolute bioavailability in a single experiment.

摘要

静脉注射维拉帕米后,其血浆浓度-时间曲线可用单指数或双指数方程最好地描述。总血浆清除率(1.26升/分钟)接近肝脏血流量(1.5升/分钟),因此可以得出结论,其清除率取决于肝脏血流量。尽管口服给药后吸收几乎完全,但由于广泛的肝脏首过代谢,绝对生物利用度(20%)较低。使用稳定同位素标记和未标记药物的方法允许通过血管内和血管外途径同时给药,从而可以在单个实验中测定绝对生物利用度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验